WS #13298
AstraZeneca reportedly explored a ~$400B merger with Bristol Myers Squibb, which would create the third-largest pharma company.
Pharma mega-merger speculation
AstraZeneca reportedly explored a ~$400B merger with Bristol Myers Squibb, which would create the third-largest pharma company.